Friday, June 9, 2023
Surgeons, physicians, scientists, medicinal pharmacologists and drug industry developers who are interested in the epidemiology, risk factors, treatment and outcome of surgical infections due to gram-positive pathogens.
Gram positive pathogens are increasingly identified as causing serious
infections in surgical patients. Over the last few years, the
bacteriology, presentation, virulence and treatment have evolved.
Methicillin-resistant
S aureus (MRSA) has become widespread in hospitals and intensive
care units around the world. MRSA is now one of the most common causes
of bacterial nosocomial infections, accounting for 40-70% of the
S aureus infections in intensive care units. In the past,
acquisition of MRSA colonization or infection was generally considered
to be restricted to the nosocomial setting. However, in the past decade
new strains of MRSA have emerged in the community, causing aggressive
infections in young, otherwise healthy people. Identifying this
changing cause of soft tissue infection and the need for new consensus
and guidelines are obvious. Suppurative skin infections and severe
necrotizing pneumonias are the most well-known clinical syndromes
caused by these new strains. The increasing prevalence of
community-acquired MRSA in multiple countries and the substantial
morbidity and mortality associated with these infections suggest that
community-acquired MRSA will continue to develop into a challenging
public-health problem which all physicians should become aware. In
recent years, serious skin and soft tissue infections (SSTIs) caused by
multidrug resistant pathogens have become more common. While the
majority of SSTIs are caused by Staphylococcu
S aureus or beta-haemolytic streptococci that are
methicillin/oxacillin susceptible, the emergence of
methicillin-resistant and vancomycin-resistant community-acquired and
nosocomial Gram-positive pathogens has created a need for different
therapeutic agents. While antibiotics are important, the identification
of patients who need immediate surgical treatment is paramount.
While pneumonia and soft-tissue infections seem to be increasing
due to community acquired MRSA, bacteremia and endocarditis continue to
have significant morbidity and mortality. Recent publications have
documented the importance of both prevention and treatment of this
morbid disease.
Upon completion of this activity, participants should be able to:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated time to complete activity 2.5 hours.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this
online educational activity. For information on applicability and
acceptance of continuing education credit for this activity, please
consult your professional licensing board.
This activity is designed to be completed within the time
designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To
successfully earn credit, participants must complete the activity
online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
processing....
